Literature DB >> 12363472

Multicolor-FISH analysis of a natural killer cell line (NK-92).

Roderick A F MacLeod1, Stefan Nagel, Maren Kaufmann, Karin Greulich-Bode, Hans G Drexler.   

Abstract

Relatively little is known about the cytogenetics of natural killer (NK) neoplasms, and the emergence of recurrent structural alterations involving specific chromosomal breakpoints is still in its infancy. This gap has doubtless hampered identification of the oncogene alterations posited to underly NK tumors. We describe in detail the cytogenetic rearrangements present in a cytotoxic NK cell line (NK-92) established from a patient with large granular lymphocyte (LGL) lymphoma. The NK-92 cell line is one of very few cytotoxic NK cell lines described and the first to be used clinically. Cytogenetic analysis was performed independently using two multicolor-fluorescence in situ hybridization (M-FISH) systems, the first M-FISH study of a cell line derived from a NK neoplasm. Several non-random cytogenetic features previously reported in NK cells were, thus, identified, including rearrangements of chromosomes 7 and 17, along with breakpoints at 11q23, 12q12 and 8p22/23. FISH revealed that NK-92 cells carry multiple rearrangements with distinct breakpoints at 8p resembling those previously described in NK lymphoma. Our data strengthen the claim of NK-92 to model NK neoplasms and highlight this cell line as a potential resource for mining relevant oncogenic changes therein.

Entities:  

Mesh:

Year:  2002        PMID: 12363472     DOI: 10.1016/s0145-2126(02)00055-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping.

Authors:  Michael R Rossi; Jeff Laduca; John K Cowell; Bejai I S Srivastava; Seiichi Matsui
Journal:  Leuk Res       Date:  2007-07-20       Impact factor: 3.156

Review 2.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 3.  Utilizing chimeric antigen receptors to direct natural killer cell activity.

Authors:  David L Hermanson; Dan S Kaufman
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

Review 4.  Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.

Authors:  Rohtesh S Mehta; Katayoun Rezvani
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 5.  Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy.

Authors:  Ahmet Yilmaz; Hanwei Cui; Michael A Caligiuri; Jianhua Yu
Journal:  J Hematol Oncol       Date:  2020-12-07       Impact factor: 17.388

Review 6.  Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.

Authors:  Faroogh Marofi; Heshu Sulaiman Rahman; Lakshmi Thangavelu; Aleksey Dorofeev; Favian Bayas-Morejón; Naghmeh Shirafkan; Navid Shomali; Max Stanley Chartrand; Mostafa Jarahian; Ghasem Vahedi; Rebar N Mohammed; Somayeh Shahrokh; Morteza Akbari; Farhad Motavalli Khiavi
Journal:  Stem Cell Res Ther       Date:  2021-03-22       Impact factor: 6.832

7.  B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors.

Authors:  Lisa Borghesi; Lih-Yun Hsu; Juli P Miller; Michael Anderson; Leonard Herzenberg; Leonore Herzenberg; Mark S Schlissel; David Allman; Rachel M Gerstein
Journal:  J Exp Med       Date:  2004-02-09       Impact factor: 14.307

Review 8.  You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy.

Authors:  Aline Pfefferle; Nicholas D Huntington
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.